These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15228615)

  • 1. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman S; Fleischmann R; Morgan GJ
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S3-S11. PubMed ID: 15228615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in rheumatoid arthritis.
    Sharma PK; Hota D; Pandhi P
    J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis.
    De Filippis L; Caliri A; Anghelone S; Scibilia G; Lo Gullo R; Bagnato G
    Panminerva Med; 2006 Jun; 48(2):129-35. PubMed ID: 16953150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for the treatment of rheumatoid arthritis.
    Miyasaka N
    Expert Rev Clin Immunol; 2009 Jan; 5(1):19-26. PubMed ID: 20476896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective use of TNF antagonists.
    Yocum D
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S24-30. PubMed ID: 15228618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Jones RE; Moreland LW
    Bull Rheum Dis; 1999; 48(3):1-4. PubMed ID: 10408141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing joint damage as the best measure of biologic drug therapy.
    Bresnihan B
    J Rheumatol Suppl; 2002 Sep; 65():39-43. PubMed ID: 12236622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF inhibitors in the treatment of arthritis.
    Lorenz HM
    Curr Opin Investig Drugs; 2000 Oct; 1(2):188-93. PubMed ID: 11249572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab treatment of rheumatoid arthritis.
    Maini SR
    Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNFalpha therapy for rheumatoid arthritis: an update.
    Taylor PC
    Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW
    South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-TNF-alpha chimeric antibody (infliximab)].
    Amano K
    Nihon Rinsho; 2007 Jul; 65(7):1197-201. PubMed ID: 17642232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone and cartilage destruction in RA and its intervention. Biological agents].
    Kameda H
    Clin Calcium; 2012 Feb; 22(2):223-8. PubMed ID: 22298076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of biological drugs in rheumatoid arthritis.
    Atzeni F; Benucci M; Sallì S; Bongiovanni S; Boccassini L; Sarzi-Puttini P
    Autoimmun Rev; 2013 Mar; 12(5):575-9. PubMed ID: 23219774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.